Skip to content

Evaluation of the Wits Workout Wellness Program for Older Adults

Evaluation of the Wits Workout Wellness Program for Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04928885
Enrollment
285
Registered
2021-06-16
Start date
2021-07-07
Completion date
2022-08-30
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline, Health Behaviors, Self Efficacy, Social Isolation

Keywords

Cognitive Health, Older Adults, Socialization

Brief summary

About 11% of the U.S. older adult population is at risk for or suffers from subjective cognitive decline. While some factors such as genetics and habitual physiological changes that affect brain health cannot be changed, research has shown that lifestyle changes such as participation in regular physical activity, staying socially engaged, and managing stress and diet can help to delay or reduce cognitive decline. Yet few brain health promotion programs exist and those that do fail to focus on global health and wellness as a strategy to improve brain health. Wits Workout is a holistic, 12-session, 60-minute per session, multi-modal workshop series that offers adults ages 50 and older facilitated, interactive dialogue and activities about behaviors that promote brain health. Each week includes a different themed module which has four activities and a training component.

Detailed description

While research has shown that lifestyle changes such as participation in regular physical activity, staying socially engaged, and managing stress can help to delay or reduce cognitive decline, few cognitive brain health programs exist. Those that do are targeted to a specific audience (i.e., Alzheimer's and related dementias) and primarily focus on one health domain (i.e. physical activity, diet) without the additional focus on multi-dimensions of health, which can also include intellectual engagement, social isolation, stress, sleep, and self-efficacy. Thus, there is a need for a more holistic cognitive health program aimed toward the general older adult population and particularly those that are underserved due to geographic location. Wits Workout, is a multi-modal 12-session (60 min/week) workshop series designed to enhance brain health among people ages 50 and older. Wits Workout addresses multiple factors that affect cognitive health such as physical activity, diet, intellectual engagement, social isolation, stress, sleep, and self-efficacy. The holistic workshop series is designed to be lay-leader led, interactive, and experiential. Preliminary evaluations demonstrate that this educational series serves a need in reducing isolation, increasing physical activity, promoting intellectual engagement, and enhancing overall brain health in older participants, all of which complement current aging brain health research. The researchers propose to conduct a two-arm randomized controlled trial with a treatment (workshop) group (n=120) and wait-list control group (n=120) who will receive the program after the 6-month study period is completed.

Interventions

BEHAVIORALWits Workout Program

12 week, one hour per week multi-modal, interactive training.

OTHERControl Group that receives intervention after the study

The control group will not receive the intervention during study period but will take baseline, 3 mos and 6 mos surveys. They will complete the workshop after the study period is over.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Two-arm, randomized trial with a treatment group and a waitlist control group.

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 50 years or older * English-speaking and/or able to understand English * Have no diagnosis of Alzheimer's or related dementia * Score 28 or higher on the TICS cognitive screening * Able to participate in the 12 week program * Have not previously participated in a Wits Workout program

Exclusion criteria

* Under age 50, * Unable to speak or understand English, * Have a diagnosis of Alzheimer's or related dementia, * Score lower than 28 on TICS * Plan to miss more than two weeks of the program (i.e. traveling during that time period) * Have previously participated in a Wits Workout program.

Design outcomes

Primary

MeasureTime frameDescription
Change in Cognitive FunctionBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselineThe PROMIS Cognitive Function measure used to measure cognitive functioning. Raw score is converted into the T-score, with 50 being the mean score. 10 T-score is one standard deviation. Therefore, score above 50 means that a person is better than the average population in mental ability, and lower score meaning worse or disability. The score changing over time can indicate decline in cognitive function (lower score) or improved cognitive function (higher score) or no decline or improvement (same score).
Change in Cognitive StatusBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselineTelephone Interview for Cognitive Status (TICS). Used to measure cognitive status. For TICS - the minimum = 0 maximum = 50. Higher scores mean better cognition.

Secondary

MeasureTime frameDescription
StressBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselinePerceived Stress Scale (PSS). Total scores range from 0 to 40. Higher scores indicate higher stress.
Change in Social SatisfactionBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselineSocial Provisions Scale. Range of total score should be 24-96 with higher scores being a better outcome.
Self-efficacyBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselinePROMIS general self efficacy short-form. Survey scores are changed into a T score, with a mean of 50 and a standard deviation of 10. The higher the score the greater the self-efficacy.
Change in SleepBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselinePittsburgh Sleep Quality Index (PSQI). The PSQI has 7 sections which are scored. The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.
Change in Physical Activity LevelsBaseline prior to the workshop, at 3 months after baseline and at 6 months after baselinePhysical Activity Scale for the Elderly (PASE). Scores range from 0 to 793, with higher scores indicating greater physical activity

Countries

United States

Participant flow

Participants by arm

ArmCount
WW Treatment Group
Individuals will receive the 12-week Wits Workout Program. Individuals will take the baseline, 3 mos and 6 mos follow-up surveys. They will also take the Wits Workout satisfaction survey and participate in the 6 mos focus-groups. Wits Workout Program: 12 week, one hour per week multi-modal, interactive training.
152
WW Control Group
Individuals will be on a waitlist and will take the baseline, 3 mos and 6 mos. assessments. They will receive the Wits Workout workshop after the 6 month study period is completed. Control Group that receives intervention after the study: The control group will not receive the intervention during study period but will take baseline, 3 mos and 6 mos surveys. They will complete the workshop after the study period is over.
133
Total285

Baseline characteristics

CharacteristicWW Treatment GroupTotalWW Control Group
Age, Continuous66.05921053 Years
STANDARD_DEVIATION 10.24936345
65.58246 Years
STANDARD_DEVIATION 9.607676
65.03759398 Years
STANDARD_DEVIATION 8.82438599
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants13 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
146 Participants272 Participants126 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants2 Participants
Race (NIH/OMB)
Black or African American
14 Participants22 Participants8 Participants
Race (NIH/OMB)
More than one race
2 Participants6 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
134 Participants253 Participants119 Participants
Region of Enrollment
United States
152 participants285 participants133 participants
Sex: Female, Male
Female
136 Participants257 Participants121 Participants
Sex: Female, Male
Male
16 Participants28 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 1520 / 133
other
Total, other adverse events
0 / 1520 / 133
serious
Total, serious adverse events
0 / 1520 / 133

Outcome results

Primary

Change in Cognitive Function

The PROMIS Cognitive Function measure used to measure cognitive functioning. Raw score is converted into the T-score, with 50 being the mean score. 10 T-score is one standard deviation. Therefore, score above 50 means that a person is better than the average population in mental ability, and lower score meaning worse or disability. The score changing over time can indicate decline in cognitive function (lower score) or improved cognitive function (higher score) or no decline or improvement (same score).

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Loss to follow-up

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupChange in Cognitive Function3 Months0.28 T scoreStandard Deviation 4.27
WW Treatment GroupChange in Cognitive Function6 Months1.84 T scoreStandard Deviation 7.93
WW Control GroupChange in Cognitive Function3 Months.65 T scoreStandard Deviation 4.08
WW Control GroupChange in Cognitive Function6 Months-.73 T scoreStandard Deviation 6.97
Primary

Change in Cognitive Status

Telephone Interview for Cognitive Status (TICS). Used to measure cognitive status. For TICS - the minimum = 0 maximum = 50. Higher scores mean better cognition.

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Loss to follow-up

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupChange in Cognitive Status3 Months.96 score on a scaleStandard Deviation 4.02
WW Treatment GroupChange in Cognitive Status6 Months1.42 score on a scaleStandard Deviation 4.15
WW Control GroupChange in Cognitive Status3 Months.92 score on a scaleStandard Deviation 4.17
WW Control GroupChange in Cognitive Status6 Months1.22 score on a scaleStandard Deviation 4.21
Secondary

Change in Physical Activity Levels

Physical Activity Scale for the Elderly (PASE). Scores range from 0 to 793, with higher scores indicating greater physical activity

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Number analyzed changes due to loss to follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupChange in Physical Activity LevelsBaseline68.21 score on a scaleStandard Deviation 50.3
WW Treatment GroupChange in Physical Activity Levels3 Months57.34 score on a scaleStandard Deviation 43.05
WW Treatment GroupChange in Physical Activity Levels6 Months68.35 score on a scaleStandard Deviation 48.37
WW Control GroupChange in Physical Activity LevelsBaseline71.29 score on a scaleStandard Deviation 63.85
WW Control GroupChange in Physical Activity Levels3 Months64.84 score on a scaleStandard Deviation 60.41
WW Control GroupChange in Physical Activity Levels6 Months66.95 score on a scaleStandard Deviation 35
Secondary

Change in Sleep

Pittsburgh Sleep Quality Index (PSQI). The PSQI has 7 sections which are scored. The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Loss to follow-up

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupChange in Sleep3 Months0.21 score on a scaleStandard Deviation 1.82
WW Treatment GroupChange in Sleep6 Months7.23 score on a scaleStandard Deviation 2.51
WW Control GroupChange in Sleep3 Months-.17 score on a scaleStandard Deviation 1.77
WW Control GroupChange in Sleep6 Months-6.37 score on a scaleStandard Deviation 2.38
Secondary

Change in Social Satisfaction

Social Provisions Scale. Range of total score should be 24-96 with higher scores being a better outcome.

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Loss to follow-up

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupChange in Social Satisfaction3 Months.30 score on a scaleStandard Deviation 5.72
WW Treatment GroupChange in Social Satisfaction6 Months0.23 score on a scaleStandard Deviation 12.69
WW Control GroupChange in Social Satisfaction3 Months-.72 score on a scaleStandard Deviation 5.86
WW Control GroupChange in Social Satisfaction6 Months-.43 score on a scaleStandard Deviation 12.79
Secondary

Self-efficacy

PROMIS general self efficacy short-form. Survey scores are changed into a T score, with a mean of 50 and a standard deviation of 10. The higher the score the greater the self-efficacy.

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Sample size varies by time point due to drop out/loss to follow up.

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupSelf-efficacyBaseline46.89 T-scoreStandard Deviation 8
WW Treatment GroupSelf-efficacy3 Months48.10 T-scoreStandard Deviation 8.47
WW Treatment GroupSelf-efficacy6 Months50.49 T-scoreStandard Deviation 8.48
WW Control GroupSelf-efficacyBaseline49.61 T-scoreStandard Deviation 8.93
WW Control GroupSelf-efficacy3 Months50.22 T-scoreStandard Deviation 8.33
WW Control GroupSelf-efficacy6 Months49.28 T-scoreStandard Deviation 7.97
Secondary

Stress

Perceived Stress Scale (PSS). Total scores range from 0 to 40. Higher scores indicate higher stress.

Time frame: Baseline prior to the workshop, at 3 months after baseline and at 6 months after baseline

Population: Sample sizes change by time point due to loss to follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
WW Treatment GroupStressBaseline21 score on a scaleStandard Deviation 3.89
WW Treatment GroupStress3 Months19.94 score on a scaleStandard Deviation 3.31
WW Treatment GroupStress6 Months19.65 score on a scaleStandard Deviation 3.26
WW Control GroupStressBaseline20.62 score on a scaleStandard Deviation 3.5
WW Control GroupStress3 Months20.26 score on a scaleStandard Deviation 3.34
WW Control GroupStress6 Months20.34 score on a scaleStandard Deviation 3.89

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026